Equity | 10. Equity The following table summarizes the changes in our stockholders’ equity for the three months ended September 30, 2024 and 2023 (amounts in thousands, except share amounts): Shares Common Additional Retained Cumulative Accumulated Non- Total Three months ended September 30, 2024 Balance at June 30, 2024 103,034,602 $ 1,030 $ 1,810,678 $ 121,538 $ ( 630,738 ) $ 2,344 $ 67,622 $ 1,372,474 Stock based compensation, net — — 125 — — — ( 306 ) ( 181 ) Dividends and distributions paid 0.265 per share) — — — — ( 27,304 ) — ( 1,551 ) ( 28,855 ) Issuance of common stock, net 2,631,727 26 35,007 — — — — 35,033 Unrealized loss on interest rate swaps — — — — — ( 1,855 ) ( 97 ) ( 1,952 ) Net income — — — 4,863 — — 252 5,115 Allocation of non-controlling interest — — ( 539 ) — — — 539 — Balance at September 30, 2024 105,666,329 $ 1,056 $ 1,845,271 $ 126,401 $ ( 658,042 ) $ 489 $ 66,459 $ 1,381,634 Three months ended September 30, 2023 Balance at June 30, 2023 93,415,706 $ 934 $ 1,673,399 $ 102,491 $ ( 524,806 ) $ 4,518 $ 165,531 $ 1,422,067 Stock based compensation — — 134 — — — 1,524 1,658 Dividends and distributions paid 0.265 per share) — — — — ( 24,756 ) — ( 3,399 ) ( 28,155 ) Redemption of common units for shares of common stock 1,821 — 24 — — — ( 24 ) — Issuance of common stock, net 1,700,000 17 33,662 — — — — 33,679 Unrealized loss on interest rate — — — — — ( 88 ) ( 22 ) ( 110 ) Net income — — — 5,374 — — 707 6,081 Allocation of non-controlling interest — — ( 77 ) — — — 77 — Balance at September 30, 2023 95,117,527 $ 951 $ 1,707,142 $ 107,865 $ ( 549,562 ) $ 4,430 $ 164,394 $ 1,435,220 The following table summarizes the changes in our stockholders' equity for the nine months ended September 30, 2024 and 2023 (amounts in thousands, except share amounts): Shares Common Additional Retained Cumulative Accumulated Non- Total Nine months ended September 30, 2024 Balance at December 31, 2023 100,973,247 $ 1,010 $ 1,783,338 $ 112,301 $ ( 576,319 ) $ 1,871 $ 87,315 $ 1,409,516 Stock based compensation, net — — 325 — — — 1,883 2,208 Dividends and distributions paid 0.795 per share) — — — — ( 81,723 ) — ( 4,660 ) ( 86,383 ) Grant of unvested restricted stock 35,623 — — — — — — — Redemption of common units for 1,436,085 14 18,779 — — — ( 18,793 ) — Issuance of common stock, net 3,221,374 32 42,893 — — — — 42,925 Unrealized loss on interest rate swaps, net — — — — — ( 1,382 ) ( 99 ) ( 1,481 ) Net income — — — 14,100 — — 749 14,849 Allocation of non-controlling interest — — ( 64 ) — — — 64 — Balance at September 30, 2024 105,666,329 $ 1,056 $ 1,845,271 $ 126,401 $ ( 658,042 ) $ 489 $ 66,459 $ 1,381,634 Nine months ended September 30, 2023 Balance at December 31, 2022 90,814,021 $ 908 $ 1,622,913 $ 93,497 $ ( 475,983 ) $ 3,546 $ 166,101 $ 1,410,982 Stock based compensation — — 427 — — — 4,198 4,625 Dividends and distributions paid 0.795 per share) — — — — ( 73,579 ) — ( 10,195 ) ( 83,774 ) Grant of unvested restricted stock 32,486 — — — — — — — Redemption of common units for 12,020 — 164 — — — ( 164 ) — Issuance of common stock, net 4,259,000 43 85,868 — — — — 85,911 Contribution of property for — — — — — — 219 219 Unrealized gain on interest rate — — — — — 884 100 984 Net income — — — 14,368 — — 1,905 16,273 Allocation of non-controlling interest — — ( 2,230 ) — — — 2,230 — Balance at September 30, 2023 95,117,527 $ 951 $ 1,707,142 $ 107,865 $ ( 549,562 ) $ 4,430 $ 164,394 $ 1,435,220 A summary of dividends declared by our board of directors per share of common stock and per common unit at the date of record is as follows: Quarter Declaration Date Record Date Payment Date Dividend (1) Q1 2024 April 25, 2024 May 9, 2024 May 21, 2024 0.265 Q2 2024 July 17, 2024 August 1, 2024 August 13, 2024 0.265 Q3 2024 October 31, 2024 November 15, 2024 November 27, 2024 0.265 (1) Prior to the end of the performance period as set forth in the applicable LTIP unit award, holders of performance-based LTIP units are entitled to receive dividends per LTIP unit equal to 10 % of the dividend paid per common unit. After the end of the performance period, the number of LTIP units, both vested and unvested, that LTIP award recipients have earned, if any, are entitled to receive dividends in an amount per LTIP unit equal to dividends, both regular and special, payable per common unit. Holders of LTIP units that are not subject to the attainment of performance goals are entitled to receive dividends per LTIP unit equal to 100 % of the dividend paid per common unit beginning on the grant date. ATM Programs We entered into separate equity distribution agreements on each of December 20, 2019 (the “2019 ATM Program”) and June 22, 2021 (the “2021 ATM Program” and, together with the 2019 ATM Program, the “ATM Programs”) with various financial institutions pursuant to which we may issue and sell shares of our common stock having an aggregate offering price of up to $ 300.0 million under each ATM Program from time to time in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”). Under each of the ATM Programs, we may enter into one or more forward transactions (each, a “forward sale transaction”) under separate master forward sale confirmations and related supplemental confirmations with each of the various financial institutions party to the respective ATM Program for the sale of shares of our common stock on a forward basis. The following table sets forth certain information with respect to issuances under the 2019 ATM Program during the nine months ended September 30, 2024 (amounts in thousands except share amounts): 2019 ATM Program For the three months ended Number of Shares Issued (1) Net Proceeds (1) March 31, 2024 — $ — June 30, 2024 589,647 7,903 September 30, 2024 2,631,727 35,077 Total 3,221,374 $ 42,980 (1) Shares issued by us, which were all issued in settlement of forward sale transactions. As of September 30, 2024, we had settled all of our outstanding forward sale transactions under the 2019 ATM Program. We accounted for the forward sale transactions as equity. No sales of shares of our common stock were made under the 2021 ATM Program during the nine months ended September 30, 2024. As of September 30, 2024, we had approximately $ 300.0 million of gross sales of our common stock available under the 2021 ATM Program and $ 43.9 million of gross sales of common stock available under the 2019 ATM Program. Share Repurchase Program On April 28, 2022, our Board of Directors authorized a share repurchase program whereby we may repurchase up to 4,538,994 shares of our common stock, or approximately 5 % of our outstanding shares as of the authorization date. We are not required to purchase shares under the share repurchase program, but may choose to do so in the open market or through privately negotiated transactions at times and amounts based on our evaluation of market conditions and other factors. No repurchases of shares of our common stock were made under the share repurchase program during the nine months ended September 30, 2024 . |